CIK 0001635077 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Aclarion, Inc.
Sign in to watch- Ticker
- ACON
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 473324725
- Phone
- 833 275 2266
- Business address
- 8181 ARISTA PLACE, STE 100, BROOMFIELD, CO, 80021
- Former names
- Nocimed, Inc.
Securities
- ACON Common Stock Nasdaq
- ACONW Warrant Nasdaq
- 8-K Event Material agreement · Executive or director change · Regulation FD disclosure
- 10-Q Report Quarterly Report
- 8-K Event Shareholder vote results
- DEFA14A Proxy Proxy Materials
- 8-K Event Shareholder vote results · Regulation FD disclosure
- 8-K Event Executive or director change
- 10-Q Report Quarterly Report
- DEF 14A Proxy Proxy Statement
- EFFECT Other Notice of Effectiveness
- PRE 14A Proxy Proxy Statement (Preliminary)
- CORRESP Other Correspondence Between Filers and SEC Staff
- UPLOAD Other SEC-generated Letter
- S-3 Offering Registration Statement
- 8-K Event Regulation FD disclosure
- 10-K Report Annual Report
- NT 10-K Other NT 10-K
- 8-K Event Shareholder rights changed · Bylaws or fiscal year change
- 8-K Event Other events
- 8-K Event Shareholder vote results
- 8-K Event Shareholder vote results · Regulation FD disclosure
Page 3 of 14 · 276 filings